Safety of Laparoscopic Surgery for Benign Diseases during Pregnancy: A Nationwide Retrospective Cohort Study.


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
Historique:
received: 25 04 2018
revised: 06 06 2018
accepted: 08 06 2018
pubmed: 18 6 2018
medline: 1 8 2019
entrez: 18 6 2018
Statut: ppublish

Résumé

To compare fetal, maternal, and operative outcomes of laparoscopic surgery versus laparotomy for major benign diseases including appendicitis, cholecystitis, adnexal masses, and uterine myoma during pregnancy. Retrospective cohort study (Canadian Task Force classification II-2). The Diagnosis Procedure Combination database, a national inpatient database for acute care inpatients in Japan. Eligible patients (n = 6018) underwent abdominal surgery (4047 laparotomy and 1971 laparoscopy patients) from July 2010 through March 2016. The 2 groups were compared using propensity score matching analysis. The primary outcome was fetal adverse events, including abortion or stillbirth within 7 days after surgery and premature delivery during hospitalization. Secondary outcomes were operative time, blood transfusion, and length of hospital stay after surgery. Propensity score matching created 740 pairs. Significant difference was observed in the primary outcome between propensity score-matched patients in the laparotomy versus laparoscopy group (1.8% vs .41%, respectively; risk difference, -1.4%; 95% confidence interval, -2.4 to -.30; p = .01). Compared with the laparotomy group, the laparoscopy group had a significantly lower incidence of blood transfusion (2.3% vs .41%, p = .002), shorter operative time (115 vs 95 minutes, p <.001), and shorter hospital stay (9.2 vs 5.9 days, p <.001). Our current study using propensity score matching suggests the advantages of laparoscopic surgery for benign diseases compared with laparotomy because laparoscopic surgery had advantages in short-term fetal adverse events, incidence of blood transfusion, operative time, and hospital stay.

Identifiants

pubmed: 29909089
pii: S1553-4650(18)30314-5
doi: 10.1016/j.jmig.2018.06.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

501-506

Informations de copyright

Copyright © 2018 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Daisuke Shigemi (D)

Department of Clinical Epidemiology and Health Economics (Drs. Shigemi, Aso, Matsui, and Yasunaga), School of Public Health, The University of Tokyo, Tokyo, Japan. Electronic address: dshigemi@m.u-tokyo.ac.jp.

Shotaro Aso (S)

Department of Clinical Epidemiology and Health Economics (Drs. Shigemi, Aso, Matsui, and Yasunaga), School of Public Health, The University of Tokyo, Tokyo, Japan.

Hiroki Matsui (H)

Department of Clinical Epidemiology and Health Economics (Drs. Shigemi, Aso, Matsui, and Yasunaga), School of Public Health, The University of Tokyo, Tokyo, Japan.

Kiyohide Fushimi (K)

Department of Health Policy and Informatics (Dr. Fushimi), Tokyo Medical and Dental University Graduate School, Tokyo, Japan.

Hideo Yasunaga (H)

Department of Clinical Epidemiology and Health Economics (Drs. Shigemi, Aso, Matsui, and Yasunaga), School of Public Health, The University of Tokyo, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH